| CEO: | Adrian Kinkaid |
| Chairman: | Simon Gordon Douglas |
| Chief Scientific Officer: | Richard John Buick |
| Non-Executive Dir: | Colin Walsh, Matthew Baker |
| Address: | Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast, United Kingdom, BT17 0QL |
| Website: | https://www.fusionantibodies.com/ |
| Sector: | Health Care(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB00BDQZGK16 |
| Currency | UK Pounds |
| Share Price | 14.50p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 19.25 |
| 52 Week Low | 5.80 |
| Volume | 210,569 |
| Shares Issued | 113.66m |
| Market Cap | £16.48m |
| RiskGrade | 464 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 11:03 | 40,000 @ 14.10p |
| 10:05 | 10,000 @ 14.31p |
| 09:27 | 67 @ 14.76p |
| 09:13 | 9,639 @ 14.32p |
| 09:02 | 40,000 @ 14.32p |
| Chair | Simon Gordon Douglas |
| CEO | Adrian Kinkaid |
You are here: research